Canada's Biorem Q2 revenue rises 66% on project execution

Biorem

28/07/2026 13:09

Overview
Canada clean tech firm's Q2 revenue rose 66% yr/yr on strong project execution
Net income and EPS for Q2 increased significantly from prior year
Company repurchased shares under normal course issuer bid during the quarter

Outlook
Company did not provide specific guidance for future quarters or full year

Result Drivers
PROJECT EXECUTION - Co said project execution exceeded expectations and contributed to higher revenue and profitability
NEW PROJECTS - 20 new projects secured in the quarter helped maintain order backlog at near record levels
HIGHER SALES EXPENSES - Increase in operating expenses was mainly due to higher variable sales expenses on increased revenue

Company press release: ID:nCNW6hdc5a

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
 
C$15.69 mln
 
Q2 EPS
 
C$0.11
 
Q2 Net Income
 
C$2.70 mln
 
Q2 Basic EPS
 
C$0.12
 
Q2 Gross Profit
 
C$4.91 mln
 
Q2 Operating Expenses
 
C$2.18 mln
 

Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the environmental services & equipment peer group is "buy"
Wall Street's median 12-month price target for Biorem Inc is C$3.50, about 15.5% above its July 27 closing price of C$3.03

Reuters Recommended Reads
July 28 - Canada's Tamarack Valley Q2 revenue rises on higher oil prices
July 28 - Finland's Lamor Q2 revenue falls on weak orders
July 27 - Canada's First Capital REIT Q2 net income plunges on impairment, credit losses

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)